Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Blood (2022) 140 (Supplement 1): 10598–10600.

https://doi.org/10.1182/blood-2022-158213

Published: 2022

Journal Articles

Chemotherapy with the Use of TKIs Based on MRD Has the Potential to Avoid Hematopoietic Stem Cell Transplantation in Treatment for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL). Results of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study ALL-Ph13

Atsushi Sato, Hirohide Kawasaki, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Sachiko Yonezawa, Chiyo K Imamura, Haruko Shima, Hirotoshi Sakaguchi, Yuichi Kodama, Keisuke Kato, Motohiro Kato, Hidefumi Hiramatsu, Nobutaka Kiyokawa, Akiko Kada, Akiko M Saito, Keizo Horibe, Atsushi Manabe, Hiroyuki Shimada

Blood (2021) 138 (Supplement 1): 3394.

https://doi.org/10.1182/blood-2021-148264

Published: 2021

Journal Articles

Additional Evidence of Mismatch Repair Pathway As Relapse-Specific Alteration in B-Cell Precursor Acute Lymphoblastic Leukemia: Discovery of Novel Somatic Mutation in MLH1 and Establishment of New Cell Line with MLH1 Mutation

Keisuke Kato, MD, Ai Yoshimi, MD, Norihito Ikenobe, MD, Chie Kobayashi, MD PhD, Kazutoshi Koike, MD, Masahiro Tsuchida, MD PhD

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-142122

Published: 2020

Journal Articles

Massive Parallel Sequencing and Mutations Analysis of Mismatch Repair Genes in Recurrent Childhood Acute Lymphoblastic Leukemia Cases-Identification of Possible Molecular Signature of Poor Clinical Outcome

Keisuke Kato, MD, Ai Yoshimi, MD, Satoru Matsushima, MD, Chie Kobayashi, MD, Kunio Fukuda, MD, Kazutoshi Koike, MD, Masahiro Tsuchida, MD PhD

Blood (2016) 128 (22): 5266.

https://doi.org/10.1182/blood.V128.22.5266.5266

Published: 2016

Journal Articles

Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia

Koji Kato, Motohiro Kato, Daiichiro Hasegawa, Hirohide Kawasaki, Hiroyuki Ishida, Yasuhiro Okamoto, Katsuyoshi Koh, Masami Inoue, Jiro Inagaki, Keisuke Kato, Hisashi Sakamaki, Hiromasa Yabe, Keisei Kawa, Ritsuro Suzuki, Yoshiko Atsuta

Blood (2015) 125 (8): 1352–1354.

https://doi.org/10.1182/blood-2014-10-604702

Published: 2015

Journal Articles

Comparison of Stem Cell Transplantation with Reduced Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for Children with Acute Lymphoblastic Leukemia

Koji Kato, MDPhD, Motohiro Kato, MD PhD, Daiichiro Hasegawa, MD, Hirohide Kawasaki, MD, Hiroyuki Ishida, MD PhD, Yasuhiro Okamoto, MD, Katsuyoshi Koh, MD PhD, Masami Inoue, MD, Jiro Inagaki, MD, Keisuke Kato, MD, Hisashi Sakamaki, MDPhD, Hiromasa Yabe, MD PhD, Keisei Kawa, MD PhD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD

Blood (2014) 124 (21): 544.

https://doi.org/10.1182/blood.V124.21.544.544

Published: 2014

Journal Articles

Long-Term Outcome of Six Months Maintenance Chemotherapy for ALL in Children: An Extended Follow up Study of TCCSG L92-13

Motohiro Kato, Atsushi Manabe, MD PhD, Sae Ishimaru, Daisuke Tomizawa, MD PhD, Daisuke Hasegawa, MD PhD, Takeshi Inukai, MD PhD, Yuki Arakawa, Takahiro Aoki, MD, Mayuko Okuya, Kiyohiko Kaizu, Keisuke Kato, MD, Yuichi Taneyama, Katsuyoshi Koh, MD PhD, Masahiro Tsuchida, MD PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 2262.

https://doi.org/10.1182/blood.V124.21.2262.2262

Published: 2014

Journal Articles

T Cell Lymphoblastic Leukemia with PICALM-MLLT10/t(10;11)(p13;q21) in a Fraction of Childhood ETP-ALL. -Molecular Study of Childhood T Cell Lymphoblastic Leukemia,

Keisuke Kato, MD, Ai Yoshimi, MD, Tomohei Nakao, MD, PhD, Chie Kobayashi, MD, PhD, Kazutoshi Koike, MD, Nobutaka Kiyokawa, MD, PhD, Masahiro Tsuchida, MD, PhD

Blood (2011) 118 (21): 3553.

https://doi.org/10.1182/blood.V118.21.3553.3553

Published: 2011

Journal Articles

Cytogenetic/Molecular Findings and Treatment Outcome of Childhood Acute Megakaryoblastic Leukemia. Possible Favorable Effect of High Dose Cytarabine and Stem Cell Transplantation.

Keisuke Kato, MD, Ayako Tagusagawa, MD, Chie Kobayashi, MD, Ph.D, Kazutoshi Koike, MD, Masahiro Tsuchida, MD, Ph.D

Blood (2007) 110 (11): 4255.

https://doi.org/10.1182/blood.V110.11.4255.4255

Published: 2007

NARROW

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Additional Evidence of Mismatch Repair Pathway As Relapse-Specific Alteration in B-Cell Precursor Acute Lymphoblastic Leukemia: Discovery of Novel Somatic Mutation in MLH1 and Establishment of New Cell Line with MLH1 Mutation

Massive Parallel Sequencing and Mutations Analysis of Mismatch Repair Genes in Recurrent Childhood Acute Lymphoblastic Leukemia Cases-Identification of Possible Molecular Signature of Poor Clinical Outcome

Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia

Comparison of Stem Cell Transplantation with Reduced Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for Children with Acute Lymphoblastic Leukemia

Long-Term Outcome of Six Months Maintenance Chemotherapy for ALL in Children: An Extended Follow up Study of TCCSG L92-13

T Cell Lymphoblastic Leukemia with PICALM-MLLT10/t(10;11)(p13;q21) in a Fraction of Childhood ETP-ALL. -Molecular Study of Childhood T Cell Lymphoblastic Leukemia,

Cytogenetic/Molecular Findings and Treatment Outcome of Childhood Acute Megakaryoblastic Leukemia. Possible Favorable Effect of High Dose Cytarabine and Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only